First Horizon Advisors Inc. Trims Stake in ARK Genomic Revolution ETF (BATS:ARKG)

First Horizon Advisors Inc. lessened its holdings in shares of ARK Genomic Revolution ETF (BATS:ARKG) by 11.7% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 4,104 shares of the company’s stock after selling 546 shares during the quarter. First Horizon Advisors Inc.’s holdings in ARK Genomic Revolution ETF were worth $105,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of the business. EverSource Wealth Advisors LLC bought a new stake in shares of ARK Genomic Revolution ETF during the 1st quarter worth approximately $49,000. Cetera Investment Advisers lifted its position in shares of ARK Genomic Revolution ETF by 290.7% during the first quarter. Cetera Investment Advisers now owns 140,897 shares of the company’s stock worth $4,052,000 after purchasing an additional 104,831 shares during the last quarter. CWM LLC lifted its position in shares of ARK Genomic Revolution ETF by 7.7% during the second quarter. CWM LLC now owns 48,260 shares of the company’s stock worth $1,133,000 after purchasing an additional 3,432 shares during the last quarter. SG Americas Securities LLC boosted its stake in shares of ARK Genomic Revolution ETF by 5.4% during the second quarter. SG Americas Securities LLC now owns 129,356 shares of the company’s stock valued at $3,037,000 after purchasing an additional 6,675 shares during the period. Finally, Wealth Enhancement Advisory Services LLC grew its holdings in shares of ARK Genomic Revolution ETF by 10.7% in the second quarter. Wealth Enhancement Advisory Services LLC now owns 44,424 shares of the company’s stock worth $1,043,000 after purchasing an additional 4,305 shares during the last quarter.

ARK Genomic Revolution ETF Trading Up 2.6 %

ARKG stock opened at $23.83 on Friday. The business has a 50 day moving average of $24.69 and a 200-day moving average of $25.11.

ARK Genomic Revolution ETF Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.